IART Integra LifeSciences Holdings Corporation

NASDAQ
$12.33

Integra LifeSciences Holdings Corporation (IART) is expected to report earnings on January 20, 2027, before the market open. The consensus earnings estimate is $0.65 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.5% since its last earnings release on October 21, 2026.

Integra LifeSciences Holdings Beat Consensus Estimates, Guides Below Estimates
Wednesday, October 21, 2026 · 6:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 20
Wednesday · 6:00 AM ET
Earnings Whisper
-
vs $0.65
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $15.51

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is engaged in the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.